This inventor holds 3 USPTO granted patents. Top assignee: Albert Einstein College of Medicine. Active years: 1999-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2009
Title: Innovations of Bruce D Gaynor: Pioneering Peptides in Lupus Research
Introduction
Bruce D Gaynor, a notable inventor based in Pelham, NY, has made significant contributions to the field of medical research, particularly focusing on systemic lupus erythematosus. With three patents to his name, he has leveraged his expertise to develop innovative peptides that aid in the diagnosis and treatment of this chronic autoimmune disease.
Latest Patents
Gaynor's latest inventions center around peptides that are valuable in detecting anti-double stranded DNA antibodies. One of his patents details a method for identifying a peptide that effectively binds to these antibodies. This innovation not only enhances the detection process but also includes the creation of a class of peptides that can be utilized in compositions for better diagnosis and treatment of systemic lupus erythematosus. This pioneering work underscores the potential of these peptides in transforming approaches to manage the disease effectively.
Career Highlights
Bruce D Gaynor is affiliated with the Albert Einstein College of Medicine, where he has dedicated his career to advancing medical research and innovation. His work has significantly impacted the understanding and treatment of autoimmune diseases, positioning him as a leading figure in his field.
Collaborations
Throughout his career, Gaynor has collaborated with esteemed colleagues such as Betty A Diamond and Matthew D Scharff. These partnerships have played a crucial role in enhancing his research and advancing the development of groundbreaking peptides that address critical health challenges.
Conclusion
In conclusion, Bruce D Gaynor's contributions to the field of medical research, particularly through his patents on peptides for detecting and treating systemic lupus erythematosus, exemplify the impactful role of inventors in healthcare innovation. His ongoing efforts at the Albert Einstein College of Medicine continue to inspire advancements in understanding autoimmune disorders, making substantial strides toward improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile